Up a level |
Pivot, Xavier B and Bondarenko, Igor and Dvorkin, Mikhail and Trishkina, Ekaterina and Ahn, Jin-Hee and Im, Seock-Ah and Sarosiek, Tomasz and Chattopadhyay, Sanjay and Wojtukiewicz, Marek and Moiseyenko, Vladimir and Shparyk, Yaroslav V and Bello, Maximino De Guzman and Semiglazov, Vladimir and Song, Sujeong and Lim, Jae Yun (2017) A randomized, double-blind, phase III study comparing SB3 (trastuzumab biosimilar) with originator trastuzumab in patients treated by neoadjuvant therapy for HER2-positive early breast cancer. Journal of Clinical Oncology, 35 (15). p. 509. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)